# PRISM (Broad Institute)

Scripts and documentation for analyzing PRISM drug screening data from the Broad Institute with IHK-44. 

PRISM (Profiling Relative Inhibition Simultaneously in Mixtures) is a high-throughput pooled screening platform that quantifies compound sensitivity across hundreds of cancer cell lines using a molecular barcoding method. 

Resources: https://www.theprismlab.org/, https://depmap.org/repurposing/, https://pmc.ncbi.nlm.nih.gov/articles/PMC7328899/
